M&G Investment Management LTD Vertex Pharmaceuticals Inc Transaction History

M&G Investment Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $188,064 - $214,538	664 New	664 $209,000
Q3 2022 Nov 01, 2022	BUY	$273.83 - $305.53 $203,181 - $226,703	742 New	742 $215,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $3.87 Million - $4.88 Million	-21,836 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $4.09 Million - $4.83 Million	21,836 New	21,836 $4.41 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $188,595 - $219,833	-911 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$207.01 - $276.09 $626,412 - $835,448	-3,026 Reduced 76.86%	911 $215,000
Q2 2020 Jul 22, 2020	SELL	$225.48 - $295.8 $503,947 - $661,113	-2,235 Reduced 36.21%	3,937 $1.14 Million
Q1 2020 Apr 09, 2020	SELL	$199.77 - $247.81 $51,740 - $64,182	-259 Reduced 4.03%	6,172 $1.47 Million
Q4 2019 Jan 28, 2020	BUY	$166.71 - $223.91 $1.07 Million - $1.44 Million	6,431 New	6,431 $1.41 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.